Prospective multicenter study of the impact of the 21-gene recurrence score (RS) assay on medical oncologist (MO) and patient (pt) adjuvant breast cancer (BC) treatment selection

被引：0
|
作者：
Lo, S. S.
Norton, J.
Mumby, P. B.
Smerage, J.
Kash, J.
Chew, H. K.
Hayes, D.
Epstein, A.
Albain, K. S.
机构：
[1] Loyola Univ, Maywood, IL 60153 USA
[2] Univ Michigan, Ann Arbor, MI 48109 USA
[3] Edward Hosp, Naperville, IL USA
[4] Univ Calif Davis, Sacramento, CA 95817 USA
[5] Mt Sinai Med Ctr, New York, NY 10029 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
577
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Prospective Evaluation of the 21-Gene Recurrence Score Assay for Breast Cancer Decision-Making in Ontario
    Levine, Mark N.
    Julian, Jim A.
    Bedard, Philippe L.
    Eisen, Andrea
    Trudeau, Maureen E.
    Higgins, Brian
    Bordeleau, Louise
    Pritchard, Kathleen I.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (10) : 1065 - +
  • [22] The impact of the 21-gene assay on adjuvant treatment decisions in oestrogen receptor-positive early breast cancer: a prospective study
    Anna Kuchel
    Tim Robinson
    Charles Comins
    Mike Shere
    Mohini Varughese
    Geoff Sparrow
    Ajay Sahu
    Louise Saunders
    Amit Bahl
    Simon J Cawthorn
    Jeremy P Braybrooke
    British Journal of Cancer, 2016, 114 : 731 - 736
  • [23] Outcome disparities by age and 21-gene recurrence score (RS) in hormone receptor positive (HR) breast cancer (BC).
    Petkov, Valentina I.
    Miller, Dave P.
    Howlader, Nadia
    Gliner, Nathan
    Howe, Will
    Schussler, Nicola C.
    Cronin, Kathleen
    Baehner, Frederick L.
    Penberthy, Lynne
    Shak, Steven
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [24] Metabolic syndrome and breast cancer recurrence within the 21-gene recurrence score assay.
    Muniz, Jeanette
    Kidwell, Kelley M.
    Henry, Norah Lynn
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (28)
  • [25] Associations between metabolic syndrome, breast cancer recurrence, and the 21-gene recurrence score assay
    Muniz, Jeanette
    Kidwell, Kelley M.
    Henry, N. Lynn
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 157 (03) : 597 - 603
  • [26] First Prospective Multicenter Italian Study on the Impact of the 21-Gene Recurrence Score in Adjuvant Clinical Decisions for Patients with ER Positive/HER2 Negative Breast Cancer
    Dieci, Maria Vittoria
    Guarneri, Valentina
    Giarratano, Tommaso
    Mion, Marta
    Tortora, Giampaolo
    De Rossi, Costanza
    Gori, Stefania
    Oliani, Cristina
    Merlini, Laura
    Pasini, Felice
    Bonciarelli, Giorgio
    Griguolo, Gaia
    Orvieto, Enrico
    Michieletto, Silvia
    Saibene, Tania
    Del Bianco, Paola
    De Salvo, Gian Luca
    Conte, PierFranco
    ONCOLOGIST, 2018, 23 (03): : 297 - 305
  • [27] A prospective clinical utility and pharmacoeconomic study of the impact of the 21-gene Recurrence Score® assay in oestrogen receptor positive node negative breast cancer
    Davidson, J. A.
    Cromwell, I.
    Ellard, S. L.
    Lohrisch, C.
    Gelmon, K. A.
    Shenkier, T.
    Villa, D.
    Lim, H.
    Sun, S.
    Taylor, S.
    Taylor, M.
    Czerkawski, B.
    Hayes, M.
    Ionescu, D. N.
    Yoshizawa, C.
    Chao, C.
    Peacock, S.
    Chia, K.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (11) : 2469 - 2475
  • [28] Impact of the 21-gene recurrence score assay in adjuvant chemotherapy selection for node-negative, hormone receptor-positive breast cancer in the Chinese population
    Zhang, Y. N.
    Zhou, Y. D.
    Mao, F.
    Sun, Q.
    NEOPLASMA, 2015, 62 (04) : 658 - 665
  • [29] Associations between metabolic syndrome, breast cancer recurrence, and the 21-gene recurrence score assay
    Jeanette Muniz
    Kelley M. Kidwell
    N. Lynn Henry
    Breast Cancer Research and Treatment, 2016, 157 : 597 - 603
  • [30] Concordance between the 21-gene recurrence score (RS) and the 70-gene profile (MP) in breast cancer (BC) patients (pts)
    Denduluri, N.
    Rugo, H. S.
    Davis, S. E.
    Favret, A.
    Hong, R.
    Au, A.
    Moore, D. H.
    Esserman, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (27)
12345